Ryan Spencer is the founder of Dynavax Technologies. Dynavax Technologies has raised $2.2B in total funding. Latest round: IPO. Backed by Sanofi.
Ryan Spencer is the Chief Executive Officer of Dynavax Technologies, a biotechnology company known for vaccines like HEPLISAV-B. He joined Dynavax in 2005 as an interim controller and has since become CEO, leading the company through its acquisition by Sanofi.
Full founder directory · Investor directory · Company funding database · Fundraising library